TME Pharma Eulerpool Novinky

TME Pharma Novinky o akciách

TME Pharma sledujú mnohí novinári a investori po celom svete. Najaktuálnejšie správy TME Pharma zhromažďujeme práve tu.

• 8. júla ·

  Yahoo
  TME Pharma: Termination of the Liquidity Contract
• 27. mája ·

  Yahoo
  TME Pharma Provides Additional Details on the Debt and Warrant Agreements Announced on 21 May That Extend Its Financial Visibility by 12 Months
• 5. mája ·

  Yahoo
  TME Pharma Announces New Strategy
• 10. apríla ·

  Yahoo
  TME Pharma Provides Update on Resources Allocated to the Liquidity Contract With Invest Securities
• 13. marca ·

  Yahoo
  TME Pharma Announces Filing of Patents for Use of CCL2 Inhibitor NOX-E36 in Ophthalmology and Presentation at ARVO 2025 of Preclinical Data Showing Benefit in Glaucoma Filtration Surgery
• 17. februára ·

  Yahoo
  TME Pharma CEO Message
• 29. januára ·

  Yahoo
  TME Pharma Announces Collaboration with aimed analytics for AI-Driven Drug Discovery and Optimization
• 23. decembra ·

  Yahoo
  TME Pharma Announces Successful Completion of €2.6 Million Public Offer With Strong Shareholder Support
• 31. októbra ·

  Yahoo
  TME Pharma Awarded €2.4 Million German Federal Grant to Support NOX-A12 Phase 2 Trial in Brain Cancer
• 19. septembra ·

  Yahoo
  TME Pharma Announces Acceptance of the NCI’S Abstract on NOX-A12 in Glioblastoma for Presentation at the SNO 2024 Annual Meeting